Skip to main content
Fig. 9 | Microbial Cell Factories

Fig. 9

From: Oral administration of a recombinant modified RBD antigen of SARS-CoV-2 as a possible immunostimulant for the care of COVID-19

Fig. 9

Indirect ELISA titration against recombinant RBP from E. coli of pre-immune (black) and hyperimmune female (left) and male (right) mice sera using RBD (grey) and RBD-P (light grey) antigens administrated orally (A, B) and intramuscularly (C, D). Results are presented as the mean and standard deviation of at least triplicates. There is a significant difference (p < 0.05) in all cases when the results using RBD (grey) and RBD-P (light grey) are compared for each dilution evaluated

Back to article page

Microbial Cell Factories

ISSN: 1475-2859

Contact us